SCARB2 and central nervous system cancer: Interestingly, inconsistent with the IHC protein staining results, patients with glioma with high WHO grade and histological type (GBM) showed a decreased SCARB2 mRNA expression (Figures 4B, C; p < 0.05, p < 0.01, p < 0.001).